Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11324701 | 0.77 | ALOX5 (0.43) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL25291027 | 0.75 | FURIN (0.35) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL19421430 | 0.73 | CREBBP (0.48) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL31357848 | 0.73 | CREBBP (0.48) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL18898339 | 0.73 | ALOX5 (0.43) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL19421423 | 0.73 | CREBBP (0.48) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL18612790 | 0.70 | MEN1 (0.41) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL31357816 | 0.70 | KMT2A (0.65) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL31357808 | 0.69 | KMT2A (0.50) | ALOX5MEN1KMT2AMAPTLMNA | |
| SCHEMBL31357784 | 0.66 | MEN1 (0.47) | MEN1KMT2AMAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170281702-A1 | METHOD OF ISOLATING ANTI-VIRAL INGREDIENTS FROM BAPHICACANTHUS CUSIA, COMPOSITIONS COMPRISING THEM AND THEIR MEDICAL USE | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (MO) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281702-A1 | METHOD OF ISOLATING ANTI-VIRAL INGREDIENTS FROM BAPHICACANTHUS CUSIA, COMPOSITIONS COMPRISING THEM AND THEIR MEDICAL USE | LSS, UGT1A7, LARP7 | ALOX5 2762/4885MEN1 4613/4885KMT2A 4177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.